Minoxidil Inteli

Minoxidil, the active ingredient in Minoxidil Inteli, is a Vasodilator presented as an unspecified strength topical solution for cutaneous use. It is used to treat androgenetic alopecia by promoting hair growth in both men and women.

GNH USA supplies Minoxidil Inteli as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Minoxidil is a vasodilator that acts on the hair follicle growth cycle, primarily used for androgenetic alopecia. - Male pattern androgenetic alopecia: promotes regrowth of scalp hair in men. - Female pattern androgenetic alopecia: promotes regrowth of scalp hair in women. - Age‑related hair thinning: may improve overall hair density on the scalp.

Common Side Effects: - Scalp irritation: itching, burning, or stinging at the application site. - Dryness or flaking of the scalp skin. - Redness or mild erythema. - Unwanted facial or body hair growth (hypertrichosis). - Contact dermatitis: localized rash. - Temporary shedding of existing hair.

Serious or Rare Side Effects: - Severe allergic reaction: swelling, hives, or difficulty breathing. - Significant hypotension from systemic absorption. - Chest pain or palpitations. - Rapid heart rate (tachycardia). - Persistent edema of the hands or feet. - Unexplained weight gain due to fluid retention.

Before using Minoxidil Inteli, consider the following precautions: - Pregnancy: safety not established; avoid use unless clearly needed. - Breastfeeding: unknown safety; consult a healthcare professional. - Pre‑existing scalp conditions: do not apply to irritated, infected, or inflamed skin. - Age restriction: not recommended for children under 18 years. - Concurrent topical products: monitor for increased irritation when used with other hair‑care agents. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Minoxidil may interact with other medications as follows: Major Interactions (Avoid): - Systemic antihypertensives (e.g., oral beta‑blockers, ACE inhibitors): risk of additive hypotensive effect. - Oral vasodilators (e.g., nitroglycerin): may cause excessive blood pressure lowering. - Other topical minoxidil products: risk of overdose and systemic side effects. Moderate Interactions (Monitor Closely): - Topical corticosteroids: may increase percutaneous absorption of minoxidil. - Hair dyes or chemical treatments: may heighten local skin irritation.